Duplex ultrasound and efficacy criteria in foam sclerotherapy from the 2nd European Consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany.
Duplex ultrasound and efficacy criteria in foam sclerotherapy from the 2nd European Consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany.
复制标题
泡沫硬化治疗的双重超声和疗效标准，来自 2006 年德国泰根湖第二届欧洲泡沫硬化治疗共识会议。
DOI：
10.1024/0301-1526.37.1.90
复制
发表时间：
2008
期刊：
影响因子：
--
通讯作者：
Jan
中科院分区：
文献类型：
--
作者：
F. Breu;S. Guggenbichler;Jan
理由
泡沫硬化疗法的传播导致硬化疗法作为静脉曲张的非侵入性治疗方法的复兴。2006年4月在泰根塞举行的欧洲专家委员会扩大会议是由新的发现和该方法的持续进一步发展所推动的，特别是关于“泡沫硬化疗法中（双重）超声的作用”和“泡沫硬化疗法的治疗效果评价”的主题。认为这些标准对于泡沫硬化疗法是“非特异性的”，并且可能也适用于其他静脉内消融手术。第二届欧洲泡沫硬化治疗共识会议（2nd ECMFS）的组织者随后被要求在这份单独的出版物中发表这些建议。第二届ECMFS的全部建议在本杂志上发表了广泛的概述（VASA 2008; 37;增刊71：1-32）。
方法
29名参与者事先收到了一份全面的问卷，涵盖了泡沫硬化疗法的所有相关方面。组织者根据结果起草了各种初步声明。在会议期间，与会者修改和/或批准和/或拒绝了这些声明。关于“非特定”专题，两个工作组负责对这些项目进行最后评估。最终结果于2007年3月和4月提交。
结果
对于泡沫硬化疗法，双功超声在治疗前诊断、治疗监测/指导、治疗后疗效评价和监测中具有重要意义。在静脉曲张的治疗前诊断中，准确定位功能不全的隐静脉、交通静脉和交通静脉非常重要。双功超声是用于此目的的公认金标准。在泡沫硬化疗法期间应用超声成像增加了在某些适应症中进入静脉的安全性，并且它可以帮助做出关于要注射的泡沫体积、患者的位置或患者应该执行的特定运动的决定。治疗后，可以根据推荐的定义排列双功能超声的结果、临床结果和患者的症状。这允许对治疗结果进行分级，并使不同治疗方案或不同治疗之间具有更好的可比性。除了评估治疗成功率外，多普勒超声是排除或确认深静脉血栓形成或疾病进展等并发症的首选方法。
RATIONALE
The spread of foam sclerotherapy has resulted in the renaissance of sclerotherapy as a non-invasive treatment method for varicosis. An expanded European expert committee meeting in Tegernsee in April 2006 was prompted by new findings and continuous further development of the method and worked especially on the topics "The role of (duplex) ultrasound in Foam sclerotherapy" and "Evaluation of therapeutic effects of foam Sclerotherapy". It was felt that these criteria are"non-specific" to foam sclerotherapy and would possibly also be suitable for other endovenous ablative procedures. The organisers of the 2nd European Consensus Meeting on foam sclerotherapy (2nd ECMFS) were then asked to publish these recommendations in this separate publication. The entire recommendations of the 2nd ECMFS are published in an extensive overview in this journal (VASA 2008; 37; Supplement 71: 1-32).
METHODOLOGY
The 29 participants were sent a comprehensive questionnaire in advance covering all the relevant aspects of foam sclerotherapy. The organisers drew up various preliminary statements on the basis of the results. During the meeting itself the participants revised and/or approved and/or rejected these statements. For the "non-specific" topics, two working groups were given the task of conducting the concluding assessment of these items. Their final results were presented in March and April 2007.
RESULTS
For foam sclerotherapy, duplex ultrasound is important in pre-treatment diagnosis, treatment monitoring/guidance, post-treatment efficacy evaluation and surveillance. In the pre-treatment diagnosis of varicose veins, the exact localisation of the insufficient saphenous, communicating and perforating veins is important. Duplex ultrasound is the accepted gold standard for this purpose. The application of ultrasound imaging during foam sclerotherapy increases the safety of accessing the vein in certain indications, and it can help when making a decision concerning the foam volumes to be injected, the patients' position or specific movements the patients should perform. Following treatment, the findings of duplex ultrasound, the clinical findings and the patients' symptoms can be arranged according to the recommended definitions. This allows grading of the therapeutic outcome and enables a better comparability between different treatment protocols or different treatments. Besides the evaluation of treatment success, duplex ultrasound is the method of choice to exclude or confirm complications such as deep venous thrombosis or disease progression.